Boone Capital Management LLC
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), Boone Capital Management LLC reported 16 stock positions worth $305.0 million. Its top holding was Medtronic (MDT) at 13.4% of the portfolio, followed by Mirum Pharmaceuticals (MIRM, 12.9%) and Ionis Pharmaceuticals (IONS, 9.0%). Compared with Q2 2025, it opened 8 new positions, sold out of 3, added to 1 and reduced 4. The biggest buy was a new position in Ionis Pharmaceuticals (IONS) and the biggest sale an exit from Avantor (AVTR).
- Most Recent 13F
- Q2 2026
- Location
- ATLANTA, GA
- CIK
- 0001882053
- Portfolio Value
- $305.0M (Q3 2025)
- SEC Filing
- 0001214659-25-016617 ↗ filed Nov 14, 2025
Holdings Value
Holdings 16 stocks · $305.0M
| MDT Medtronic PLC | 13.39% | 428,789 | $40.8M | No change |
| MIRM Mirum Pharmaceuticals Inc. | 12.88% | 535,732 | $39.3M | Reduce -16.5% |
| IONS Ionis Pharmaceuticals Inc. | 8.96% | 417,833 | $27.3M | New |
| CI The Cigna Group | 7.84% | 82,972 | $23.9M | Add +133.1% |
| BBIO Bridgebio Pharma Inc. | 7.84% | 460,282 | $23.9M | New |
| NBIX Neurocrine Biosciences Inc. | 7.66% | 166,414 | $23.4M | Reduce -7.7% |
| RAPT Rapt Therapeutics Inc. | 6.62% | 782,461 | $20.2M | New |
| UNH Unitedhealth Group Inc. | 6.58% | 58,112 | $20.1M | No change |
| BMRN Biomarin Pharmaceutical Inc. | 5.83% | 328,546 | $17.8M | Reduce -26.6% |
| ICLR Icon PLC | 5.50% | 95,832 | $16.8M | No change |
| COGT Cogent Biosciences Inc. | 4.45% | 945,042 | $13.6M | New |
| KOD Kodiak Sciences Inc. | 3.84% | 715,877 | $11.7M | New |
| LIVN Livanova PLC | 2.88% | 167,932 | $8.8M | New |
| QURE Uniqure NV | 2.82% | 147,317 | $8.6M | New |
| CLPT Clearpoint Neuro Inc. | 2.03% | 283,912 | $6.2M | New |
| ABEO Abeona Therapeutics Inc. | 0.87% | 502,854 | $2.7M | Reduce -59.9% |
Portfolio Sells Q2 2025 → Q3 2025
| AVTR Avantor Inc. | Sold out | 0.00% | −9.78 |
| UNM Unum Group | Sold out | 0.00% | −9.76 |
| PNTG The Pennant Group Inc. | Sold out | 0.00% | −8.31 |
| BMRN Biomarin Pharmaceutical Inc. | Reduce -26.6% | 5.83% | −4.71 |
| ABEO Abeona Therapeutics Inc. | Reduce -59.9% | 0.87% | −2.19 |
| NBIX Neurocrine Biosciences Inc. | Reduce -7.7% | 7.66% | −2.06 |
| MIRM Mirum Pharmaceuticals Inc. | Reduce -16.5% | 12.88% | −1.12 |
Portfolio Buys Q2 2025 → Q3 2025
| IONS Ionis Pharmaceuticals Inc. | New | 8.96% | +8.96 |
| BBIO Bridgebio Pharma Inc. | New | 7.84% | +7.84 |
| RAPT Rapt Therapeutics Inc. | New | 6.62% | +6.62 |
| COGT Cogent Biosciences Inc. | New | 4.45% | +4.45 |
| KOD Kodiak Sciences Inc. | New | 3.84% | +3.84 |
| LIVN Livanova PLC | New | 2.88% | +2.88 |
| QURE Uniqure NV | New | 2.82% | +2.82 |
| CI The Cigna Group | Add +133.1% | 7.84% | +2.80 |
| CLPT Clearpoint Neuro Inc. | New | 2.03% | +2.03 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 16 | $427.5M | TFX, MIRM, CI, IONS, UNH |
| Q1 2026 | 13 | $326.4M | MIRM, IONS, CI, MDT, TFX |
| Q4 2025 | 15 | $318.6M | MDT, MIRM, IONS, CI, BMRN |
| Q3 2025 | 16 | $305.0M | MDT, MIRM, IONS, CI, BBIO |
| Q2 2025 | 11 | $233.2M | MDT, MIRM, BMRN, AVTR, UNM |
| Q1 2025 | 12 | $293.8M | UNM, MDT, MIRM, GMED, CI |
| Q4 2024 | 13 | $296.5M | UNM, GMED, PRGO, MIRM, MOH |
| Q3 2024 | 17 | $385.8M | UNM, GMED, CI, MOH, CHE |
| Q2 2024 | 19 | $383.4M | UNM, GMED, CI, MOH, DHR |
| Q1 2024 | 21 | $494.4M | UNM, CI, MOH, ENOV, BAX |